Sarcoidosis-associated pulmonary hypertension (SAPH) is a very severe complication of the
disease, largely impacting its morbidity and being one of its strongest predictors of mortality …

In patients with sarcoidosis, the development of pulmonary hypertension is associated with
significant morbidity and mortality. The global prevalence of sarcoidosis-associated …

Sarcoidosis-associated pulmonary hypertension (SAPH) is found in 5 to 20% of sarcoidosis
patients. Elevated pulmonary artery pressure may be due to multiple factors, including …

Patients who complain of persistent dyspnea should be screened for the presence of
pulmonary hypertension. The prognosis of SAPH is poor and it is prudent to consider referral …

Clinicians in pulmonary medicine frequently confront the challenge of screening, diagnosis,
and management of pulmonary hypertension (PH) in sarcoidosis patients who present with …

Patients with advanced sarcoidosis may develop pulmonary hypertension for a variety of
reasons [1]. One of the earlier papers noting the incidence and severity of this problem came …

Pulmonary vascular involvement is a common complication in sarcoidosis, particularly in
advanced disease. 1 The mechanisms leading to the development of pulmonary …

Pulmonary hypertension (PH) is a well-known complication of sarcoidosis, defined by a
mean pulmonary artery pressure of≥ 25 mm Hg. Since both PH and sarcoidosis are rare …

Pulmonary hypertension (PH) is a well‐recognized complication of sarcoidosis. Patients with
sarcoidosis‐associated PH (SAPH) have poorer functional status and greater supplemental …

Sarcoidosis-associated pulmonary hypertension (SAPH) is an important complication of
advanced sarcoidosis. Over the past few years, there have been several studies dealing …